Holger Hofmeister

Dr. Holger Hofmeister advises international and German corporate clients and private equity firms on all issues relating to takeovers, acquisitions, divestitures and other corporate matters, including corporate restructurings and governance-related matters.


Dr. Hofmeister’s representative matters include advising, among others:

  • Airbnb, Inc. in its acquisition of Germany-based fewoVista S.L. & Co. KG and Vacaleo GmbH;
  • Daimler AG in connection with various matters including:
    • the carve-out and disposals of Daimler dealerships throughout Germany;
    • projects relating to the cooperation with Renault-Nissan-Alliance;
    • the sale of its subsidiary Russ & Janot GmbH to Lei Shing Hong Limited, a Hong Kong-based company engaged in automobile and heavy machinery distribution;
    • the sale of its subsidiary Taunus-Auto-Verkaufs GmbH to KBM Motorfahrzeuge GmbH & Co. KG, a German automobile and heavy machinery distributor; and
    • the divestiture of its worldwide Chrysler distribution business;
  • Dürr AG, a major German industrial machinery group, in connection with several M&A transactions including the acquisition of iTAC Software AG;
  • Fresenius SE & Co. KGaA, a health care company in Germany, in the sale of Fresenius Biotech GmbH to the Fuhrer family, owners of Neopharm Ltd., a pharmaceutical company;
  • Hillenbrand, Inc., a holding company for a funeral products manufacturer and an industrial equipment supplier, in its:
    • definitive agreement to acquire Abel GmbH & Co. KG, a manufacturer of inter alia diaphragm pumps and certain of its affiliates from Roper Technologies, Inc., a diversified technology company, for €95 million in cash; and
    • US$530 million acquisition of Coperion GmbH, a manufacturer of industrial machinery and plants, from Deutsche Beteiligungs AG, a private equity firm;
  • HSH Nordbank in connection with its restructuring resulting from EU state aid proceedings;
  • IAC/InterActive Corp in its acquisition of a majority shareholding in MyHammer Holding AG from Holtzbrinck Digital GmbH and the subsequent voluntary takeover;
  • KAP-Beteiligungs-Aktiengesellschaft in its public takeover by a subsidiary of The Carlyle Group;
  • Konecranes Plc in its US$1.5 billion acquisition of Terex Corporation’s material handling and port solutions business segment;
  • LANXESS AG, a global specialty chemicals company, in its US$2.5 billion all-cash acquisition of Chemtura Corporation;
  • Merck KGaA, a biotechnology and pharmaceutical company, a distributor of laboratory products, and a manufacturer of specialty chemicals, food additives and cosmetics, in connection with:
    • its €13.8 billion all-cash acquisition of Sigma-Aldrich Corporation and in the divestiture of certain business of Merck/Sigma-Aldrich to obtain antitrust clearance for such acquisition;
    • the US$6.7 billion sale of its worldwide generic drugs business to Mylan Laboratories, Inc. Prior to sale, the business underwent a significant reorganization with a number of related carve-out transactions to separate the generics business from the remaining Merck group;
  • Süd-Chemie AG in the formation of a US$300 million joint venture with Ashland Inc. to merge their foundry chemicals businesses under the name of ASK Chemicals GmbH;
  • Telegraaf Media Groep N.V. in the sale of its interest in SBS Broadcasting and its option to purchase a minority stake in ProSiebenSat.1 Media AG;
  • Agravis Raffeisen AG, an agricultural trading and services company, on the acquisition of Industrial Veterinaria, S.A., a Spanish manufacturer of Veterinary pharmaceuticals and nutritional products;
  • Apax Partners in connection with:
    • its proposed US$8.5 billion bid for ISS/AS, a facilities management provider, from Goldman Sachs Capital Partners and EQT Partners AB; and
    • the US$420 million sale of Versatel AG, a provider of telecommunications and information technology services, to Kohlberg Kravis Roberts & Co., a private equity firm;
  • TPV Technology Limited in the proposed acquisition of a 70 percent interest in a joint venture, which will own and control the entire television business of Koninklijke Philips Electronics N.V. in Europe and certain South American countries;
  • Koenigsegg Group in the proposed acquisition of Saab, the Swedish auto manufacturer, from General Motors;
  • Vue Entertainment Ltd. in its acquisition of CinemaxX AG from Dr. Herbert Kloiber, Dr. Kloiber Vermögensverwaltungsgesellschaft mbH & Co. Beteiligungs KG and other shareholders; Braskem S.A. in its US$323 million acquisition of the polypropylene business from The Dow Chemical Company;
  • Odewald & Compagnie, a private equity firm, in its acquisition of Oberberg Kliniken, an operator of mental health clinics;
  • Quadriga Capital and Barclays Private Equity in their sale of Jack Wolfskin GmbH, a manufacturer and retailer of sportswear and apparel, to The Blackstone Group, L.P.; and
  • Telegraaf Media Groep N.V. in the sale of its interest in SBS Broadcasting and its option to purchase a minority stake in ProSiebenSat.1 Media AG.



  • Dr. Jur., University of Regensburg, 1999
  • Second State Exam, Appellate Court of Duesseldorf, 2001
  • First State Exam, University of Regensburg, 1998


  • Frankfurt am Main

Holger Hofmeister